JP2007509928A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509928A5 JP2007509928A5 JP2006537921A JP2006537921A JP2007509928A5 JP 2007509928 A5 JP2007509928 A5 JP 2007509928A5 JP 2006537921 A JP2006537921 A JP 2006537921A JP 2006537921 A JP2006537921 A JP 2006537921A JP 2007509928 A5 JP2007509928 A5 JP 2007509928A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- formula
- bromoethyl
- bis
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *c(cc1*)c(*)cc1[N+]([O-])=O Chemical compound *c(cc1*)c(*)cc1[N+]([O-])=O 0.000 description 3
- XXEFQXVRUXNVIK-UHFFFAOYSA-N CCCN(C)CCNCC Chemical compound CCCN(C)CCNCC XXEFQXVRUXNVIK-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ529249 | 2003-10-31 | ||
| NZ529249A NZ529249A (en) | 2003-10-31 | 2003-10-31 | Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic |
| NZ535618 | 2004-09-28 | ||
| NZ53561804 | 2004-09-28 | ||
| PCT/NZ2004/000275 WO2005042471A1 (en) | 2003-10-31 | 2004-10-29 | Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007509928A JP2007509928A (ja) | 2007-04-19 |
| JP2007509928A5 true JP2007509928A5 (https=) | 2007-10-11 |
| JP4760712B2 JP4760712B2 (ja) | 2011-08-31 |
Family
ID=34555019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006537921A Expired - Fee Related JP4760712B2 (ja) | 2003-10-31 | 2004-10-29 | 新規ニトロフェニルマスタードおよびニトロフェニルアジリジンアルコールおよびそれらの対応するリン酸エステルおよびターゲットが決められた細胞毒性剤としてのそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7629332B2 (https=) |
| EP (1) | EP1680394A4 (https=) |
| JP (1) | JP4760712B2 (https=) |
| KR (1) | KR101167335B1 (https=) |
| AU (1) | AU2004285831B2 (https=) |
| BR (1) | BRPI0416085A (https=) |
| CA (1) | CA2544335A1 (https=) |
| IL (1) | IL175000A0 (https=) |
| RU (1) | RU2372324C2 (https=) |
| WO (1) | WO2005042471A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7629332B2 (en) * | 2003-10-31 | 2009-12-08 | Auckland Uniservices Limited | Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| NZ549659A (en) * | 2006-09-04 | 2008-12-24 | Auckland Uniservices Ltd | Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom |
| WO2008033039A1 (en) * | 2006-09-11 | 2008-03-20 | Adam Vorn Patterson | Cancer treatment |
| NZ549831A (en) * | 2006-09-11 | 2009-03-31 | Auckland Uniservices Ltd | Combination of docetaxel and a nitrophenyl phosphate derivative for the treatment of cancer |
| WO2008033041A1 (en) * | 2006-09-11 | 2008-03-20 | Auckland Uniservices Limited | Cancer treatment |
| EP2114157B1 (en) | 2006-12-26 | 2021-05-26 | ImmunoGenesis, Inc. | Phosphoramidate alkylator prodrug for the treatment of cancer |
| WO2009140553A2 (en) * | 2008-05-15 | 2009-11-19 | Threshold Pharmaceuticals, Inc. | Hypoxia activated drugs of nitrogen mustard alkylators |
| WO2010044685A1 (en) * | 2008-10-17 | 2010-04-22 | Auckland Uniservices Limited | Nitrophenyl mustard alcohols, their corresponding phosphates and their use as targeted cytotoxic agents |
| JP5765634B2 (ja) | 2008-10-21 | 2015-08-19 | スレッシュホールド ファーマシューティカルズ， インコーポレイテッド | 低酸素活性化型プロドラッグを用いるがんの処置 |
| CN101723932B (zh) | 2008-10-31 | 2013-11-20 | 北京以岭生物工程技术有限公司 | 硝基吡啶乙烯亚胺化合物、其药物组合物及其制备方法和用途 |
| WO2012009288A2 (en) | 2010-07-12 | 2012-01-19 | Threshold Pharmaceuticals, Inc. | Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer |
| US10357577B2 (en) | 2010-07-16 | 2019-07-23 | Auckland Uniservices Limited | Bacterial nitroreductase enzymes and methods relating thereto |
| CN104039328B (zh) * | 2011-11-11 | 2018-10-09 | 米伦纽姆医药公司 | 对蛋白酶体抑制剂的反应的生物标记 |
| WO2013096687A1 (en) | 2011-12-22 | 2013-06-27 | Threshold Pharmaceuticals, Inc. | Administration of hypoxia activated prodrugs in combination with chk1 inhibitors for treating cancer |
| WO2014007650A1 (en) * | 2011-12-23 | 2014-01-09 | Auckland Uniservices Limited | Compounds and methods for selective imaging and/or ablation |
| US10202408B2 (en) | 2012-08-23 | 2019-02-12 | Health Innovation Ventures B.V. | Prodrugs and methods of use thereof |
| CN105051004B (zh) * | 2012-08-23 | 2017-12-05 | 健康创新企业私人有限责任公司 | 新型前体药物及其使用方法 |
| WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| US20160158253A1 (en) | 2013-07-26 | 2016-06-09 | Threshold Pharmaceuticals, Inc. | Treatment of pancreatic cancer with a combination of a hypoxia-activated prodrug and a taxane |
| WO2016210175A1 (en) | 2015-06-24 | 2016-12-29 | Threshold Pharmaceuticals, Inc. | Aziridine containing dna alkylating agents |
| US10348685B2 (en) * | 2016-04-29 | 2019-07-09 | Nicira, Inc. | Priority allocation for distributed service rules |
| CN108571241B (zh) * | 2017-03-14 | 2021-08-17 | 福特环球技术公司 | 用于推按式闩锁类型车辆抽屉的惯性锁系统 |
| WO2019125184A1 (en) | 2017-12-19 | 2019-06-27 | Auckland Uniservices Limited | Use of biomarker in cancer therapy |
| WO2019190331A1 (en) * | 2018-03-29 | 2019-10-03 | Achilles Medical Limited | Prodrug compounds activated by akr1c3 and their use for treating hyperproliferative disorders |
| WO2019229195A1 (en) * | 2018-05-30 | 2019-12-05 | Convert Pharmaceuticals S.A. | Prodrugs and medical uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ240785A (en) * | 1991-11-28 | 1995-08-28 | Cancer Res Campaign Tech | Substituted nitro aniline derivatives and medicaments |
| GB9819472D0 (en) * | 1998-09-07 | 1998-10-28 | Cancer Soc Auckland Div Nz Inc | Novel nitrophenylaziridine compounds and their use as prodrugs |
| WO2003022274A2 (en) * | 2001-09-13 | 2003-03-20 | Synta Pharmaceuticals Corp. | 2-aroylimidazole compounds for treating cancer |
| NZ521851A (en) * | 2002-10-08 | 2005-02-25 | Auckland Uniservices Ltd | Nitroaniline-based unsymmetrical mustard alkylating agents for gene dependent enzyme prodrug therapy |
| US7629332B2 (en) * | 2003-10-31 | 2009-12-08 | Auckland Uniservices Limited | Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
-
2004
- 2004-10-29 US US10/577,078 patent/US7629332B2/en not_active Expired - Fee Related
- 2004-10-29 CA CA002544335A patent/CA2544335A1/en not_active Abandoned
- 2004-10-29 EP EP04817434A patent/EP1680394A4/en not_active Withdrawn
- 2004-10-29 BR BRPI0416085-1A patent/BRPI0416085A/pt not_active IP Right Cessation
- 2004-10-29 RU RU2006118785/04A patent/RU2372324C2/ru not_active IP Right Cessation
- 2004-10-29 WO PCT/NZ2004/000275 patent/WO2005042471A1/en not_active Ceased
- 2004-10-29 JP JP2006537921A patent/JP4760712B2/ja not_active Expired - Fee Related
- 2004-10-29 KR KR1020067010566A patent/KR101167335B1/ko not_active Expired - Fee Related
- 2004-10-29 AU AU2004285831A patent/AU2004285831B2/en not_active Ceased
-
2006
- 2006-04-11 IL IL175000A patent/IL175000A0/en unknown
-
2009
- 2009-08-11 US US12/461,419 patent/US20100010094A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007509928A5 (https=) | ||
| RU2006118785A (ru) | Новые нитрофенилипритные и нитрофенилазиридиновые спирты и их соответствующие фосфаты и их применение в качестве нацеленных цитотоксическихих средств | |
| US20220153738A1 (en) | Compositions and methods for modulating hair growth | |
| RU2414475C2 (ru) | Пролекарства фосфорамидатных алкилаторов | |
| US11147889B2 (en) | Albumin-binding PSMA inhibitors | |
| TWI665178B (zh) | 作為化療劑的β－取代的β－氨基酸和類似物及其應用 | |
| JP2020530007A5 (https=) | ||
| ES2988059T3 (es) | Agonistas de PPAR, compuestos, composiciones farmacéuticas y métodos de uso de los mismos | |
| HUP0301169A2 (hu) | 9-Helyzetben helyettesített minociklinszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| JP2017537940A (ja) | 増殖性疾患の処置に有用な融合１，３−アゾール誘導体 | |
| CN109071459B (zh) | Ppar激动剂、化合物、药物组合物以及它们的使用方法 | |
| JP2011057693A5 (https=) | ||
| KR20140095105A (ko) | 대장염 치료용 조성물 및 방법 | |
| AU2019418584A1 (en) | Compositions and methods for modulating hair growth | |
| CN1249036C (zh) | 铁螯合剂及其用途 | |
| RU2014113679A (ru) | N-(2-амино-6,6-дифтор-4,4а,5,6,7,7а-гексагидро-циклопента[e][1,3]оксазин-4-ил)-фенил)-амиды в качестве ингибиторов бета-секретазы 1 | |
| US20230302144A1 (en) | Porphyrin Compounds and Compositions Useful for Treating Cancer | |
| BRPI0712938A2 (pt) | mÉtodo para modular excrescÊncia de neurito pelo uso de um antagonista de receptor de galanina-3 | |
| US11312737B2 (en) | Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof | |
| TW201710251A (zh) | 作為抗癌藥劑之經官能化及取代之吲哚 | |
| CN110325508A (zh) | 雄激素受体的n-末端结构域的抑制剂 | |
| JP2020518649A5 (https=) | ||
| CA2504496A1 (en) | N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor | |
| US10072035B2 (en) | Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof | |
| TWI585066B (zh) | 作為化學治療劑之經β－取代的γ－胺基酸及類似物 |